Endocrinology Vol. 142, No. 6 2451-2457
Copyright © 2001 by The Endocrine Society
X-Linked Inhibitor of Apoptosis Protein Activates the Phosphatidylinositol 3-Kinase/Akt Pathway in Rat Granulosa Cells during Follicular Development1
Eric Asselin2,
Yifang Wang and
Benjamin K. Tsang
Reproductive Biology Unit and Division of Reproductive Medicine,
Departments of Obstetrics and Gynecology and Cellular and Molecular
Medicine, University of Ottawa; and Ottawa Health Research Institute,
The Ottawa Hospital (Civic Campus), Ottawa, Ontario, Canada K1Y
4E9
Address all correspondence and requests for reprints to: Benjamin K. Tsang, Ph.D., Ottawa Health Research Institute, The Ottawa Hospital (Civic Campus), 725 Parkdale Avenue, Ottawa, Ontario, Canada K1Y 4E9. E-mail: btsang{at}lri.ca
 |
Abstract
|
|---|
X-linked inhibitor of apoptosis protein (XIAP) in granulosa cells is
regulated by gonadotropins during follicular development, although the
current understanding of the mechanisms by which XIAP suppressed
granulosa cell apoptosis is incomplete. In the present study, we
investigated the possible involvement of the phosphatidylinositol
3-kinase (PI 3-K) survival pathway in the regulation of granulosa cell
fate. Using a fully characterized in vivo model to study
the induction of follicular development and atresia in immature rats,
we have demonstrated that gonadotropin treatment increased granulosa
cell XIAP and phospho-Akt protein contents and suppressed apoptosis. In
addition, gonadotropin withdrawal [equine CG (eCG)-primed rats treated
with an anti-eCG antibody] induced granulosa cell apoptosis and
significantly decreased ovarian weight. The increased apoptosis was
accompanied by marked decreases in XIAP expression and phosphorylation
of Akt protein. Infection of granulosa cells from eCG-primed rats with
adenoviral sense XIAP [lacZ as a control; multiplicity
of infection, 15] resulted in XIAP overexpression and increased
phospho-Akt content, whereas XIAP antisense expression (multiplicity of
infection, 1040) decreased granulosa cell phospho-Akt level and
induced apoptosis. Addition of the specific PI 3-K inhibitor LY294002
to the granulosa cell cultures decreased Akt phosphorylation and
induced apoptosis in a dose-dependent manner. Taken together, these
results demonstrate for the first time the importance and regulation of
the PI 3-K survival pathway by XIAP in the control granulosa cell
apoptosis.
 |
Introduction
|
|---|
ACTIVATION OF THE phosphatidylinositol
3-kinase (PI 3-K)/Akt pathway is important for the suppression of
apoptosis in many cell systems. First discovered as a lipid kinase that
phosphorylates phosphoinositides (PtdIns) at position 3 of
the inositol ring, PI 3-K has emerged as an important signal
transducing molecule that is activated by diverse growth factor
receptors (1). Once activated, PI 3-K phosphorylates Akt
(also known as protein kinase B or Rac kinase) in a serine/threonine
kinase survival pathway often referred to as the PI 3-K/Akt pathway
(2, 3, 4). The phosphorylated Akt, in turn, phosphorylates
and attenuates the actions of Bad, a proapoptotic member of the Bcl-2
family (5, 6).
PI 3-K is composed of a catalytic (p110) and a regulatory (p85) subunit
(7). The p110 sequence includes a p85-binding region, a
Ras-binding domain, and a catalytic core (8, 9, 10).
Similarly, the p85 sequence includes an N-terminal Src homology 3 (SH3)
domain, a Bcr homologous region flanked by two proline-rich regions,
and two SH2 domains separated by an inter-SH2 region (8, 11, 12). It has been shown that the association of p110 with the
GTP-binding protein Ras following ligand-receptor binding results in PI
3-K activation (13, 14). PI 3-K activation is also
facilitated by the association of p85 with p110 (15) and
the recruitment of the p85:p110 dimer by activated protein tyrosine
kinase (16).
The inhibitor of apoptosis proteins (IAPs) is a family of intracellular
antiapoptotic proteins that were first identified in baculovirus. They
include X-linked IAP (XIAP and cIAP-3), human IAP-1 (HIAP-1 and
cIAP-2), human IAP-2 (HIAP-2 and cIAP-1), neuronal IAP (NAIP), and
survivin (17, 18). IAPs are characterized by the presence
of a caspase recruitment domain and an N-terminal baculovirus inhibitor
of apoptosis repeat motif, which are necessary for biological activity.
With the exception of NIAP and survivin, the IAPs also contain a
C-terminal ring-zinc finger domain believed to be required for
protein-protein interactions. Only a few reports to date have addressed
the mechanisms of action of these antiapoptotic proteins. XIAP has been
shown to be a direct inhibitor of caspase-3 and caspase-7
(19) and also to modulate the Bax/cytochrome c
pathway by inhibiting caspase-9 (20). Overexpression of
XIAP has been shown to protect Chinese hamster ovary (CHO) and Rat-1
cells from menadione or growth factor withdrawal-mediated apoptosis
(18) and from apoptosis in HeLa cells induced by transient
transfection with interleukin-1ß-converting enzyme (21)
as well as suppress apoptosis induced by Sindbis virus
(22).
The presence of gonadotropin during follicular development is critical
for the selection and survival of the growing follicles (see Ref.
23 for a review). We have previously shown that IAP
contents in granulosa cells are increased during follicular growth in
response to gonadotropin stimulation in vivo and that
gonadotropin withdrawal resulted in decreased granulosa cell IAP
expression and apoptosis (24). However, the mechanism(s)
by which gonadotropin increased granulosa cell XIAP level and
suppressed apoptosis is not known. Moreover, although both PI 3-K and
IAPs are well established cell survival intermediates, if and how they
interact to determine the fate of the granulosa cells (survival
vs. apoptosis) has not been investigated. The objective of
the present study was to address this question and to determine how
XIAP block programmed cell death during follicular development.
 |
Materials and Methods
|
|---|
Reagents
Equine CG (eCG), normal rabbit serum (NRS), Hoechst 33248, and
LY294002 were supplied by Sigma (St. Louis, MO). RPMI 1640
and FBS were purchased from Life Technologies, Inc.
(Burlington, Canada). p85 PI-3K antibody was a gift from Dr. J. Liu
(Loeb Health Medical Research Institute, Ottawa, Canada). The anti-eCG
antiserum was produced in our laboratory as previously reported
(25). Rabbit anti-PhosphoPlus Akt
(Ser473) antibody for Western blot and sheep
anti-Phospho-Akt (Ser473-MN) antibody for
immunohistochemistry were obtained from New England Biolabs, Inc. (Mississauga, Canada) and Upstate Biotechnology, Inc. (Lake Placid, NY), respectively. The
Vectastain ABC kit for sheep IgG, blocking kit,
fluorescein-avidin D, and Vectashield were purchased from Vector Laboratories, Inc. (Burlingame, CA). Common antibody diluent was
supplied by BioGenex Laboratories, Inc. (San Ramon, CA).
Polyclonal rabbit antihuman XIAP antibody, adenoviral XIAP sense and
antisense full-length complementary DNA (cDNA) and lacZ were
provided by Dr. Eric LaCasse (ApoptoGen, Inc., Ottawa, Canada).
Animal preparation
Immature (2324 days of age) female Sprague Dawley rats (5060
g; Charles River Laboratories, Inc. Canada,
Montréal, Canada) were injected with eCG (15 IU, ip) or saline
(0.9% NaCl) and 24 h later, with 100 µl of either NRS (saline
and eCG groups) or anti-eCG antiserum (anti-eCG groups). Animals were
killed 24 h after NRS or antiserum injection. Ovaries were excised
and fixed in 10% formalin for XIAP immunohistochemistry and in
situ terminal deoxynucleotidyl transferase-mediated
deoxy-UTP-biotin end labeling (TUNEL) of apoptotic cells. In addition,
granulosa cells from each group of animals were harvested by follicle
puncture as previously described (25). The animals were
fed Prolab RMH4018 (Agway, Inc., Syracuse, NY) and water ad
libitum. A 14-h light, 10-h dark cycle was maintained, with light
cycle initiated at 0600 h.
Cell culture
Granulosa cells (1 x 106), isolated
24 h after eCG injection (15 IU, sc), were cultured in RPMI 1640
containing 10% FBS, 1% nonessential amino acids, 0.5%
streptomycin-penicillin, and 0.25% fungizone for 48 at 37 C in an
atmosphere of 5% CO2. For XIAP sense and
antisense adenoviral infections, the spent medium was discarded, and
0.5 ml fresh 10% FBS medium containing sense XIAP adenovirus
[multiplicity of infection (MOI), 0, 1, 2.5, and 5] or antisense XIAP
(MOI, 0, 10, 20, and 40). lacZ adenoviral vector was used as
the control and was also used in combination with XIAP sense and
antisense DNA adenovirals to attain a final viral concentration with
MOI of 5 and 40, respectively. The cells were incubated with adenoviral
vectors for 1 h with frequent shaking to ensure maximal infection
and then cultured in 2 ml FBS-free medium for 48 h. At the end of
the culture period, both floating cells and attached cells [recovered
by trypsin treatment (0.05% trypsin and 0.53 mM
EDTA, 37 C for 35 min)] were pooled and centrifuged (1900 x
g, 5 min). For protein extraction, cell pellets were
resuspended in a lysis buffer (PBS, pH 7.4) containing NaCl (150
mM), SDS (0.1%), sodium deoxycholate (0.5%),
Nonidet P-40 (1%), and the protease inhibitor
phenylmethylsulfonylfluoride (1 mM).
Immunohistochemistry
Ovarian tissues sections were deparaffinized in xylene and
rehydrated through a graded series of alcohol. Immunohistochemistry was
performed using a Dakko IHC kit (Dakko Diagnostics Canada, Inc.,
Mississauga, Canada) with slight modification to the manufacturers
procedure. Briefly, sections were blocked for 5 min with blocking
solution, washed with PBS, and incubated with polyclonal antihuman XIAP
antibody (1:50 dilution, room temperature, 1 h). Sections were
washed briefly with PBS and incubated for 30 min with a secondary
fluorescent antirabbit IgG-FITC antibody, washed again with PBS, and
mounted. For phospho-Akt immunohistochemistry, antigens were retrieved
by heating the sections with microwave in citrate buffer (0.01
M, pH 6.0) for 20 min (four times, 5 min each time). The
sections were then blocked with 1.5% normal serum containing avidin
(30 min, room temperature), incubated with sheep anti-phospho-AKT1
antibody (1:250, 1 h at room temperature or overnight at 4 C),
washed with PBS (three times for 5 min each time), and incubated with a
biotinylated secondary antibody (1:100 in PBS containing 1.5% normal
serum; 30 min at room temperature). They were again washed with PBS
(three times, 5 min each time), incubated with fluorescein-avidin D (25
µg/ml; 30 min), and mounted for fluorescence imaging.
In situ TUNEL
In situ TUNEL was carried out on ovarian sections and
cultured granulosa cells using a TUNEL kit (Roche, Laval,
Canada) in accordance with manufacturers instructions. At the end of
granulosa cell culture period, floating cells were collected by
aspiration, and cells attached to the growth surface were subjected to
trypsin treatment (0.05% trypsin and 0.53 mM
EDTA; 35 min, 37 C). The two cell fractions (floating and attached
cells) were combined, and an aliquot of this cell mixture was fixed on
a microscope slide. At least a total of 200 cells in a randomly
selected area were counted for each experimental group. The counter was
blinded and was not aware of treatment, so as to avoid experimental
bias.
Protein extraction and Western analysis
Cells were sonicated in the lysis buffer (10 sec), and the
sonicates were centrifuged (12,000 x g, 20 min, 4 C)
to remove insoluble material. Supernatant was recovered and stored at
-20 C until further processing. Protein content was determined with a
DC protein assay (Bio-Rad Laboratories, Inc., Richmond,
CA). Protein extracts were heated (3 min, 94 C), resolved by 10%
SDS-PAGE, and electrotransferred to nitrocellulose membranes (15 V, 30
min). The membranes were first stained with SYPRO Ruby protein gel
stain (Molecular Probes, Inc., Cedarlane, CA) to test
whether the protein loading was constant among samples. Total protein
stains were quantitated densitometrically. The membranes were then
blocked in PBS containing 5% milk powder (room temperature, 2 h)
and incubated (room temperature, 2 h) with antibody for XIAP
(1:2500), Akt (1:1000), or Phospho-Akt (1:1000) and subsequently with
horseradish peroxidase (HRP)-conjugated secondary antibody (1:5000,
room temperature, 45 min). Peroxidase activity was visualized with the
enhanced chemiluminescence kit (Amersham Pharmacia Biotech, Arlington Heights, IL) according to the manufacturers
instructions. The content of the protein of interest was likewise
scanned and determined by dividing its signal intensity by that of the
corresponding total protein to correct for any loading differences
between lanes.
Statistical analysis
Results are expressed as the mean ± SEM of
four experiments. Statistical analysis were carried out by one-way
ANOVA (PRISM software version 2.0, GraphPad Software, Inc., San Diego, CA). Significant differences between treatment
groups were determined by Tukeys test. Statistical significance was
inferred at P < 0.05.
 |
Results
|
|---|
Gonadotropin increases XIAP protein levels and activates the PI
3-K/Akt pathway in vivo
To examine the regulation of XIAP expression and the activation of
the PI 3-K pathway in granulosa cells after gonadotropin stimulation,
immature rats injected with eCG and 24 h later with anti-eCG or
normal rabbit serum (control) were killed 48 h after the
gonadotropin treatment (Figs. 1
and 2
). Immunohistochemical examination of
ovarian sections from eCG-treated rats revealed high Xiap and
phospho-Akt immunoreactivity as well as low TUNEL positivity in
granulosa cells whereas the opposite was true in sections from the eCG-
plus anti-eCG-treated group (Fig. 1
). A similar pattern of Xiap and
phospho-Akt immunosignals was observed in the thecal layer, although
their intensities were considerably higher. Western blot analysis of
granulosa cell extracts indicates that whereas gonadotropin treatment
in vivo increased granulosa cell XIAP (P <
0.05) and phospho-Akt (P < 0.05) contents, withdrawal
of gonadotropin support with anti-eCG antibody administration (eCG and
anti-eCG) resulted in decreases in these parameters to levels observed
in the saline group and induced apoptosis (P < 0.05;
Fig. 2
). Likewise, ovarian weight was significantly increased in the
eCG group (P < 0.05), a phenomenon effectively
attenuated by gonadotropin withdrawal. Total Akt protein content,
however, was not significantly affected by any of the treatments (Fig. 2
).

View larger version (73K):
[in this window]
[in a new window]
|
Figure 1. Immunolocalization of XIAP and phospho-Akt and
TUNEL labeling in the rat ovary. Immature rats were treated with saline
(48 h), eCG (48 h), or eCG plus anti-eCG [eCG (24 h) + anti-eCG (24
h)] as described in Materials and Methods. Ovaries were
collected, fixed in 10% formalin for 24 h, paraffin-embedded, and
sectioned for immunohistochemical and TUNEL analyses. The negative
control (NEG) indicates signals observed when the primary antibody for
XIAP and phospho-Akt was replaced with normal rabbit IgG and normal
sheep IgG, respectively, or when the terminal transferase in the TUNEL
assay was omitted. HEMA, Hematoxylin staining.
|
|

View larger version (27K):
[in this window]
[in a new window]
|
Figure 2. Effect of eCG administration and withdrawal on
granulosa cell XIAP, phospho-Akt, total Akt contents, apoptosis, and
ovarian weight in vivo. Immature rats were treated with
saline (48 h), eCG (48 h), and eCG plus anti-eCG [eCG (24 h) +
anti-eCG (24 h)]. Granulosa cells were collected by follicle puncture
and were lysed in lysis buffer for XIAP, phospho-Akt, and Akt Western
analysis (A) or fixed for TUNEL measurements (B). Densitometric
analysis (A), ovarian weight, and percent apoptosis (B) values are the
mean ± SEM of four independent experiments.
Columns with an asterisk are
significantly different from the other bars
(P < 0.05).
|
|
Antisense XIAP reduces phospho-Akt content and induces
apoptosis
To determine whether the increase in granulosa cell phospho-Akt
content following eCG treatment in vivo is due to the
activation of the PI-3K/Akt pathway by XIAP, granulosa cells from
eCG-primed rats were infected for 48 h with different
concentrations of an adenovirus containing a XIAP antisense cDNA (Fig. 3
). Down-regulation of XIAP by antisense
expression reduced phospho-Akt content (P < 0.05) and
increased apoptosis (P < 0.05) in a concentration-
dependent manner. At a MOI of 40, adenoviral XIAP antisense
significantly decreased the levels of both XIAP (P <
0.05) and phospho-Akt (P < 0.05) by 38%. Total
Akt content remained constant throughout the experiment (Fig. 3
).

View larger version (47K):
[in this window]
[in a new window]
|
Figure 3. Down-regulation of granulosa cell XIAP decreased
phospho-Akt content and induced apoptosis in vitro. One
million granulosa cells were plated in RPMI and 10% FBS for 24 h,
infected with adenoviral antisense XIAP and lacZ vector
(control) for 48 h, as described in Materials and
Methods, and collected for Western analysis and TUNEL
measurement. Densitometric and apoptosis data are the mean ±
SEM of four independent experiments. *,
P < 0.05 compared with lacZ
control.
|
|
XIAP overexpression increases Akt phosphorylation
To further characterize the relationship between XIAP and Akt
phosphorylation in the granulosa cells, the influence of XIAP
overexpression on phospho-Akt content was studied, using a sense XIAP
adenovirus (Fig. 4
). Infection of
granulosa cells with increasing concentrations of adenoviral XIAP sense
cDNA resulted in concentration-dependent increases not only in XIAP
content but also in phospho-Akt levels. Under these conditions, no
differences in total Akt protein levels were detected between
experimental groups, and the incidence of apoptosis remained low (Fig. 4
).

View larger version (51K):
[in this window]
[in a new window]
|
Figure 4. Overexpression of granulosa cell XIAP increased
phospho-Akt, but not Akt, contents. One million granulosa cells were
plated in RPMI and 10% FBS for 24 h, infected with adenoviral
sense XIAP and lacZ vector (control) for 48 h, as
described in Materials and Methods, and were collected
for Western analysis and TUNEL measurement. Densitometric and apoptosis
data are the mean ± SEM of four independent
experiments. *, P < 0.05 compared with
lacZ control.
|
|
Inhibition of PI 3-K induces apoptosis in granulosa cells
The above studies clearly demonstrated that XIAP plays an
important role in the regulation of granulosa cell phospho-Akt levels
and survival, although the mechanism involved is not clearly
understood. An increase in phospho-Akt content may be a consequence of
activation of either PI 3-K or integrin-linked kinase
(26). To address the question of whether PI 3-K is
involved and to demonstrate that this kinase is important for granulosa
cell survival, we examined the influence of the PI 3-K inhibitor
LY294002 on granulosa cell phospho-Akt content and apoptosis (Fig. 5
). The presence of LY294002
significantly decreased Akt phosphorylation and increased apoptosis in
a dose-dependent manner (P < 0.05), but had no effect
on total Akt content (Fig. 5
).

View larger version (17K):
[in this window]
[in a new window]
|
Figure 5. Effect of LY294002 on granulosa cell phospho-Akt
content and apoptosis in vitro. One million granulosa
cells were plated in RPMI and 10% FBS for 24 h before the
addition of different concentrations of LY294002. Granulosa cells were
cultured for 24 h in RPMI 1640 serum-free medium and collected for
Western analysis and TUNEL measurement. Results for apoptosis are the
mean ± SEM of three independent experiments. *,
P < 0.05 compared with control.
|
|
 |
Discussion
|
|---|
Follicular atresia is a negative and selective degenerative
process during follicular growth and development. Although granulosa
cell apoptosis has been recognized as the cellular mechanism
responsible for follicular atresia, the cross-talk between
intracellular proapoptotic and/or antiapoptotic factors is poorly
documented. In the present study we investigated the role of the PI
3-K/Akt pathway in granulosa cell survival and its regulation by XIAP.
As survival factor-promoted activation of PI 3-K appears to be
important in the suppression of apoptosis in many cellular systems, we
hypothesized that the regulation of this pathway may be crucial in
determining the fate of granulosa cells. Gonadotropins are important
survival factors during follicular development. We have previously
shown the up-regulation of XIAP in vivo in the presence of
gonadotropins (24). In this study we confirmed the
relationship between eCG and XIAP and showed that eCG induced Akt
phosphorylation/activation in granulosa cells in vivo. In
contrast, eCG withdrawal (eCG and anti-eCG treatment) reduced granulosa
cell phospho-Akt content, indicating that activation of Akt in
vivo is a gonadotropin-dependent process.
Other evidence for the importance of the PI 3-K/Akt pathway in
granulosa cell regulation came with the finding that high levels of
phosphorylated Akt were present in granulosa cells in vitro
under nonstimulated conditions. It is well established that phospho-Akt
is the active form of this protein and suppresses cell death activity
(see Ref. 27 for a review). The serine-threonine kinase
Akt has been shown to be directly phosphorylated and activated by PI
3-K. Activation of Akt, in turn, phosphorylates the proapoptotic
protein BAD, a member of the Bcl-2 family (5, 6). The
phosphorylated BAD then associates with 143-3 protein, preventing BAD
from binding with Bcl-xL and thereby promoting
cell survival (28). Whereas overexpression of BAD induced
rat granulosa cell apoptosis (29), exposure of immature
rats to eCG decreased granulosa cell phospho-BAD content
(30). Thus, the high levels of phospho-Akt in the
eCG-primed granulosa cells observed in the present study may be
important in preventing these cells from undergoing apoptosis. This
idea is supported by the observation that treatment of granulosa cells
with the specific PI 3-K inhibitor LY294002 not only significantly
decreased phospho-Akt content, but also increased apoptosis in a
concentration-dependent manner. Thus, it is possible that inhibition of
the PI 3-K pathway may be a key event in the induction of follicular
atresia in vivo, whereas activation of PI 3-K is essential
for granulosa cell survival and follicular development.
In the present study we demonstrated that XIAP is involved in the
regulation of granulosa cell Akt activity. Whereas eCG treatment
in vivo increased granulosa cell XIAP and phospho-Akt
contents, these responses were attenuated with gonadotropin withdrawal.
Moreover, adenoviral XIAP sense cDNA expression increased granulosa
cell phospho-Akt contents, whereas XIAP down-regulation by adenoviral
antisense suppressed the phosphorylation of Akt and induced apoptosis.
Total Akt levels were not affected by these treatments. Moreover, the
relative abundance of XIAP may be a key element in cell fate
determination, as it is a potent endogenous inhibitor of caspase-3, -7
(31), and -9 (20, 32). Caspases are a family
of aspartate-specific proteases that play an essential role in
maintaining cell viability because they are activated in response to a
cell death signal. We have previously demonstrated the presence of
caspase-3 in granulosa cells of atretic, but not healthy, follicles
(33). In the present study it is possible that granulosa
cell caspase activation and activity, which were otherwise suppressed
by high levels of XIAP, were reactivated when this cell survival
protein was down-regulated after antisense expression, thus
leading to increased apoptosis. Furthermore, it has been
reported that activation of Akt results in procaspase-9
phosphorylation and blockade of the caspase cascade (34),
although others have demonstrated that the Akt phosphorylation
site found in human caspase-9 was not present in mouse caspase-9
(35). The role of Akt activation in the regulation of
granulosa cell survival remains to be elucidated.
The precise mechanism(s) involved in the control of PI 3-K activity by
XIAP is not known, and different candidates may be involved.
Phosphoinositide-dependent kinase has been shown to be responsible for
Akt phosphorylation at the threonine 308 position (36),
although this phosphorylation alone was not sufficient for maximal AKT
activation, which also required serine 473 phosphorylation in a
PtdIns(3, 4, 5)P3 (the product of PI 3-K)-dependent
manner. Recently, it has been shown that integrin-linked kinase (ILK; a
serine and threonine protein kinase) may directly phosphorylate Akt on
Ser473 in vitro (26). On
the other hand, as these cellular processes are regulated by both
protein tyrosine kinases and protein tyrosine phosphatases, it is also
possible that XIAP may regulate phosphatases known to decrease PI 3-K
activity. Recombinant PTEN (a tumor suppressor protein and a
phospholipid phosphatase) is capable of dephosphorylating both
phosphotyrosine and phosphothreonine as well as the product of PI 3-K
[PtdIns (3, 4, 5)P3] (37, 38). A
recent study demonstrated high ILK activity and Akt phosphorylation in
PTEN-mutant prostate cancer cells and that PTEN wild-type transfection
suppressed ILK activity and Akt activation (39). As ILK is
sensitive to and activated by high levels of
PtdIns(3, 4, 5)P3 (26), mutation in
the PTEN gene led to PtdIns(3, 4, 5)P3 accumulation
and ILK activation. Another possible regulatory protein of PI 3-K is
the Src homology 2-containing protein tyrosine phosphatase 1, which
functions by direct association with its p85 subunit (40).
However, which of these kinases and/or phosphatases are indeed putative
candidates involved in the regulation of the phosphorylated (activated)
status of Akt and survival in granulosa cells by XIAP remains to be
determined.
In conclusion, the results of the present study demonstrate that the PI
3-K/Akt pathway has an important regulatory function in granulosa cells
during follicular development. The activation of this survival pathway
in granulosa cells is dependent on gonadotropin support and may involve
an XIAP-mediated increase in phospho-Akt content.
 |
Acknowledgments
|
|---|
We thank Dr. Eric LaCasse (ApoptoGen, Inc., Ottawa, Canada) for
providing the XIAP antibody as well as the adenoviral lacZ,
XIAP sense, and antisense cDNAs used in the present studies.
 |
Footnotes
|
|---|
1 This work was been supported by a grant from the Canadian Institutes
of Health Research (MOP-10369) and Canadian Institutes of Health
Research postdoctoral fellowships (to E.A.). 
2 Current address: Département de Chimie-Biologie, Section
Biologie Médicale, Université du Québec à
Trois-Rivières, 3351 boulevard des Forges, C.P. 500,
Trois-Rivières, Québec, Canada G9A 5H7. 
Received October 19, 2000.
 |
References
|
|---|
-
Panayotou G, Waterfield MD 1993 The assembly
of signalling complexes by receptor tyrosine kinases. BioEssays 15:171177[CrossRef][Medline]
-
Bellacosa A, de FD, Godwin AK, Bell DW, Cheng JQ,
Altomare DA, Wan M, Dubeau L, Scambia G, Masciullo V 1995 Molecular alterations of the AKT2 oncogene in ovarian and breast
carcinomas. Int J Cancer 64:280285[Medline]
-
Coffer PJ, Woodgett JR 1991 Molecular cloning and
characterisation of a novel putative protein-serine kinase related to
the cAMP-dependent and protein kinase C. Eur J Biochem 201:475481[Medline]
-
Jones PF, Jakubowicz T, Pitossi FJ, Maurer F, Hemmings
BA 1991 Molecular cloning and identification of a serine/threonine
protein kinase of the second-messenger subfamily. Proc Natl Acad Sci
USA 88:41714175[Abstract/Free Full Text]
-
Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y,
Greenberg ME 1997 Akt phosphorylation of BAD couples survival
signals to the cell-intrinsic death machinery. Cell 91:231241[CrossRef][Medline]
-
del PL, Gonzalez-Garcia M, Page C, Herrera R, Nunez
G 1997 Interleukin-3-induced phosphorylation of BAD through the
protein kinase Akt. Science 278:687689[Abstract/Free Full Text]
-
Woscholski R, Dhand R, Fry MJ, Waterfield MD, Parker
PJ 1994 Biochemical characterization of the free catalytic p110
and the complexed heterodimeric p110
.p85
forms of the mammalian
phosphatidylinositol 3-kinase. J Biol Chem 269:2506725072[Abstract/Free Full Text]
-
Dhand R, Hara K, Hiles I, Bax B, Gout I, Panayotou G,
Fry MJ, Yonezawa K, Kasuga M, Waterfield MD 1994 PI 3-kinase:
structural and functional analysis of intersubunit interactions. EMBO J 13:511521[Medline]
-
Leevers SJ, Weinkove D, MacDougall LK, Hafen E,
Waterfield MD 1996 The Drosophila phosphoinositide
3-kinase Dp110 promotes cell growth. EMBO J 15:65846594[Medline]
-
Zvelebil MJ, MacDougall L, Leevers S, Volinia S,
Vanhaesebroeck B, Gout I, Panayotou G, Domin J, Stein R, Pages F 1996 Structural and functional diversity of phosphoinositide 3-kinases.
Philos Trans R Soc Lond B Biol Sci 351:217223[Medline]
-
Holt KH, Olson L, Moye-Rowley WS, Pessin JE 1994 Phosphatidylinositol 3-kinase activation is mediated by high-affinity
interactions between distinct domains within the p110 and p85 subunits.
Mol Cell Biol 14:4249[Abstract/Free Full Text]
-
Klippel A, Escobedo JA, Hirano M, Williams LT 1994 The interaction of small domains between the subunits of
phosphatidylinositol 3-kinase determines enzyme activity. Mol Cell Biol 14:26752685[Abstract/Free Full Text]
-
Kodaki T, Woscholski R, Hallberg B, Rodriguez-Viciana P,
Downward J, Parker PJ 1994 The activation of phosphatidylinositol
3-kinase by Ras. Curr Biol 4:798806[CrossRef][Medline]
-
Rodriguez-Viciana P, Warne PH, Khwaja A, Marte BM,
Pappin D, Das P, Waterfield MD, Ridley A, Downward J 1997 Role of
phosphoinositide 3-OH kinase in cell transformation and control of the
actin cytoskeleton by Ras. Cell 89:457467[CrossRef][Medline]
-
Otsu M, Hiles I, Gout I, Fry MJ, Ruiz-Larrea F,
Panayotou G, Thompson A, Dhand R, Hsuan J, Totty N 1991 Characterization of two 85 kd proteins that associate with receptor
tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase. Cell 65:91104[CrossRef][Medline]
-
Skolnik EY, Margolis B, Mohammadi M, Lowenstein E,
Fischer R, Drepps A, Ullrich A, Schlessinger J 1991 Cloning of PI3
kinase-associated p85 utilizing a novel method for expression/cloning
of target proteins for receptor tyrosine kinases. Cell 65:8390[CrossRef][Medline]
-
Ambrosini G, Adida C, Altieri DC 1997 A novel
anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat
Med 3:917921[CrossRef][Medline]
-
Liston P, Roy N, Tamai K, Lefebvre C, Baird S,
Cherton-Horvat G, Farahani R, McLean M, Ikeda JE, MacKenzie A, Korneluk
RG 1996 Suppression of apoptosis in mammalian cells by NAIP and a
related family of IAP genes. Nature 379:349353[CrossRef][Medline]
-
Deveraux QL, Takahashi R, Salvesen GS, Reed JC 1997 X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388:300304[CrossRef][Medline]
-
Deveraux QL, Roy N, Stennicke HR, Van AT, Zhou Q,
Srinivasula SM, Alnemri ES, Salvesen GS, Reed JC 1998 IAPs block
apoptotic events induced by caspase-8 and cytochrome c by
direct inhibition of distinct caspases. EMBO J 17:22152223[CrossRef][Medline]
-
Uren AG, Pakusch M, Hawkins CJ, Puls KL, Vaux DL 1996 Cloning and expression of apoptosis inhibitory protein homologs
that function to inhibit apoptosis and/or bind tumor necrosis factor
receptor-associated factors. Proc Natl Acad Sci USA 93:49744978[Abstract/Free Full Text]
-
Duckett CS, Nava VE, Gedrich RW, Clem RJ, Van DJ,
Gilfillan MC, Shiels H, Hardwick JM, Thompson CB 1996 A conserved
family of cellular genes related to the baculovirus iap gene and
encoding apoptosis inhibitors. EMBO J 15:26852694[Medline]
-
Asselin E, Xiao CW, Wang YF, Tsang BK 2000 Mammalian follicular development and atresia: role of apoptosis. Biol
Signals Recept 9:8795[CrossRef][Medline]
-
Li J, Kim JM, Liston P, Li M, Miyazaki T, Mackenzie AE,
Korneluk RG, Tsang BK 1998 Expression of inhibitor of apoptosis
proteins (IAPs) in rat granulosa cells during ovarian follicular
development and atresia. Endocrinology 139:13211328[Abstract/Free Full Text]
-
Kim JM, Boone DL, Auyeung A, Tsang BK 1998 Granulosa cell apoptosis induced at the penultimate stage of follicular
development is associated with increased levels of Fas and Fas ligand
in the rat ovary. Biol Reprod 58:11701176[Abstract/Free Full Text]
-
Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar
S 1998 Phosphoinositide-3-OH kinase-dependent regulation of
glycogen synthase kinase 3 and protein kinase B/AKT by the
integrin-linked kinase. Proc Natl Acad Sci USA 95:1121111216[Abstract/Free Full Text]
-
Kandel ES, Hay N 1999 The regulation and activities
of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res 253:210229[CrossRef][Medline]
-
Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ 1996 Serine phosphorylation of death agonist BAD in response to
survival factor results in binding to 143-3 not BCL-X(L). Cell 87:619628[CrossRef][Medline]
-
Gebauer G, Peter AT, Onesime D, Dhanasekaran N 1999 Apoptosis of ovarian granulosa cells: correlation with the reduced
activity of ERK-signaling module. J Cell Biochem 75:547554[CrossRef][Medline]
-
Kaipia A, Hsu SY, Hsueh AJ 1997 Expression and
function of a proapoptotic Bcl-2 family member Bcl-XL/Bcl-2-associated
death promoter (BAD) in rat ovary. Endocrinology 138:54975504[Abstract/Free Full Text]
-
Takahashi R, Deveraux Q, Tamm I, Welsh K, Assa-Munt N,
Salvesen GS, Reed JC 1998 A single BIR domain of XIAP sufficient
for inhibiting caspases. J Biol Chem 273:77877790[Abstract/Free Full Text]
-
Deveraux QL, Leo E, Stennicke HR, Welsh K, Salvesen GS,
Reed JC 1999 Cleavage of human inhibitor of apoptosis protein XIAP
results in fragments with distinct specificities for caspases. EMBO J 18:52425251[CrossRef][Medline]
-
Boone DL, Tsang BK 1998 Caspase-3 in the rat ovary:
localization and possible role in follicular atresia and luteal
regression. Biol Reprod 58:15331539[Abstract/Free Full Text]
-
Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF,
Stanbridge E, Frisch S, Reed JC 1998 Regulation of cell death
protease caspase-9 by phosphorylation. Science 282:13181321[Abstract/Free Full Text]
-
Fujita E, Jinbo A, Matuzaki H, Konishi H, Kikkawa U,
Momoi T 1999 Akt phosphorylation site found in human caspase-9 is
absent in mouse caspase-9. Biochem Biophys Res Commun 264:550555[CrossRef][Medline]
-
Alessi DR, Deak M, Casamayor A, Caudwell FB, Morrice N,
Norman DG, Gaffney P, Reese CB, MacDougall CN, Harbison D, Ashworth A,
Bownes M 1997 3-Phosphoinositide-dependent protein kinase-1
(PDK1): structural and functional homology with the Drosophila DSTPK61
kinase. Curr Biol 7:776789[CrossRef][Medline]
-
Maehama T, Dixon JE 1998 The tumor suppressor,
PTEN/MMAC1, dephosphorylates the lipid second messenger,
phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273:1337513378[Abstract/Free Full Text]
-
Myers MP, Stolarov JP, Eng C, Li J, Wang SI, Wigler MH,
Parsons R, Tonks NK 1997 P-TEN, the tumor suppressor from human
chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci
USA 94:90529057[Abstract/Free Full Text]
-
Persad S, Attwell S, Gray V, Delcommenne M, Troussard A,
Sanghera J, Dedhar S 2000 Inhibition of integrin-linked kinase
(ILK) suppresses activation of protein kinase B/Akt and induces cell
cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc
Natl Acad Sci USA 97:32073212[Abstract/Free Full Text]
-
Yu Z, Su L, Hoglinger O, Jaramillo ML, Banville D, Shen
SH 1998 SHP-1 associates with both platelet-derived growth factor
receptor and the p85 subunit of phosphatidylinositol 3-kinase. J
Biol Chem 273:36873694[Abstract/Free Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
K. M. Aird, X. Ding, A. Baras, J. Wei, M. A. Morse, T. Clay, H. K. Lyerly, and G. R. Devi
Trastuzumab signaling in ErbB2-overexpressing inflammatory breast cancer correlates with X-linked inhibitor of apoptosis protein expression
Mol. Cancer Ther.,
January 1, 2008;
7(1):
38 - 47.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wang, J.-Y. Jiang, C. Zhu, C. Peng, and B. K. Tsang
Role and Regulation of Nodal/Activin Receptor-Like Kinase 7 Signaling Pathway in the Control of Ovarian Follicular Atresia
Mol. Endocrinol.,
October 1, 2006;
20(10):
2469 - 2482.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Orisaka, S. Orisaka, J.-Y. Jiang, J. Craig, Y. Wang, F. Kotsuji, and B. K. Tsang
Growth Differentiation Factor 9 Is Antiapoptotic during Follicular Development from Preantral to Early Antral Stage
Mol. Endocrinol.,
October 1, 2006;
20(10):
2456 - 2468.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Z. Spaczynski, J. L. Tilly, A. Mansour, and A. J. Duleba
Insulin and insulin-like growth factors inhibit and luteinizing hormone augments ovarian theca-interstitial cell apoptosis
Mol. Hum. Reprod.,
May 1, 2005;
11(5):
319 - 324.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Hussein
Apoptosis in the ovary: molecular mechanisms
Hum. Reprod. Update,
March 1, 2005;
11(2):
162 - 178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. E. Thompson, E. Asselin, A. Branch, J. K. Stiles, P. Sutovsky, L. Lai, G.-S. Im, R. S. Prather, S. C. Isom, E. Rucker III, et al.
Regulation of Prohibitin Expression During Follicular Development and Atresia in the Mammalian Ovary
Biol Reprod,
July 1, 2004;
71(1):
282 - 290.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Amantana, C. A. London, P. L. Iversen, and G. R. Devi
X-linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells
Mol. Cancer Ther.,
June 1, 2004;
3(6):
699 - 707.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. R. Lareu, M. D. Lacher, C. K. Bradley, R. Sridaran, R. R. Friis, and A. M. Dharmarajan
Regulated Expression of Inhibitor of Apoptosis Protein 3 in the Rat Corpus Luteum
Biol Reprod,
June 1, 2003;
68(6):
2232 - 2240.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wang, P. U. Rippstein, and B. K. Tsang
Role and Gonadotrophic Regulation of X-Linked Inhibitor of Apoptosis Protein Expression During Rat Ovarian Follicular Development In Vitro
Biol Reprod,
February 1, 2003;
68(2):
610 - 619.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Wu Xiao, E. Asselin, and B. K. Tsang
Nuclear Factor {kappa}B-Mediated Induction of Flice-Like Inhibitory Protein Prevents Tumor Necrosis Factor {alpha}-Induced Apoptosis in Rat Granulosa Cells
Biol Reprod,
August 1, 2002;
67(2):
436 - 441.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wang, S. Chan, and B. K. Tsang
Involvement of Inhibitory Nuclear Factor-{kappa}B (NF{kappa}B)-Independent NF{kappa}B Activation in the Gonadotropic Regulation of X-Linked Inhibitor of Apoptosis Expression during Ovarian Follicular Development in Vitro
Endocrinology,
July 1, 2002;
143(7):
2732 - 2740.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wang, E. Asselin, and B. K. Tsang
Involvement of Transforming Growth Factor {alpha} in the Regulation of Rat Ovarian X-Linked Inhibitor of Apoptosis Protein Expression and Follicular Growth by Follicle-Stimulating Hormone
Biol Reprod,
June 1, 2002;
66(6):
1672 - 1680.
[Abstract]
[Full Text]
[PDF]
|
 |
|